Ferritinophagy and ferroptosis in cardiovascular disease: Mechanisms and potential applications

Biomed Pharmacother. 2021 Sep:141:111872. doi: 10.1016/j.biopha.2021.111872. Epub 2021 Jul 7.

Abstract

Ferroptosis is a type of regulated cell death driven by iron dependent accumulation of cellular reactive oxygen species (ROS) when glutathione (GSH)-dependent lipid peroxidation repair systems are compromised. Nuclear receptor co-activator 4 (NCOA4)-mediated selective autophagy of ferritin, termed ferritinophagy, involves the regulation of ferroptosis. Emerging evidence has revealed that ferritinophagy and ferroptosis exert a significant role in the occurrence and development of cardiovascular disease. In the present review, we aimed to present a brief overview of ferritinophagy and ferroptosis focusing on the underlying mechanism and regulations involved. We summarize and discuss relevant research progress on the role of ferritinophagy and ferroptosis in cardiovascular diseases accompanied with potential applications of ferritinophagy and ferroptosis modulators in the treatment of ferroptosis-associated cardiovascular diseases.

Keywords: Application; Cardiovascular diseases; Ferritinophagy; Ferroptosis; Mechanism.

Publication types

  • Review

MeSH terms

  • Animals
  • Autophagy / drug effects
  • Autophagy / physiology*
  • Cardiovascular Agents / pharmacology
  • Cardiovascular Agents / therapeutic use
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / metabolism*
  • Cardiovascular Diseases / pathology
  • Ferritins / antagonists & inhibitors
  • Ferritins / metabolism*
  • Ferroptosis / drug effects
  • Ferroptosis / physiology*
  • Humans
  • Lipid Peroxidation / drug effects
  • Lipid Peroxidation / physiology
  • Myocardium / metabolism
  • Myocardium / pathology
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism

Substances

  • Cardiovascular Agents
  • Reactive Oxygen Species
  • Ferritins